Pablo G. Legorreta

Companies

• PROKIDNEY CORP.Board member Jul 13, 2022 to now¹
• Royalty Pharma plcChief executive officer Jun 15, 2020 to now²
• Royalty Pharma plcChair Jun 15, 2020 to Jun 25, 2026²
• Epizyme, Inc.Board member Nov 8, 2019 to Aug 16, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• RPRoyalty Pharma plc RPRX1,314,750 shares⁴$79.5M at $60.48Aug 7, 2026
• PPROKIDNEY CORP. PROK22,617,909 shares⁵$31.7M at $1.40Jun 3, 2025
• EEpizyme, Inc.0 shares⁶Aug 12, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 5, 2026Granted 65,216 shares of Royalty Pharma plc⁴
• May 6, 2026Granted 143,821 shares of Royalty Pharma plc⁷
• Feb 11, 2026Granted 157,828 shares of Royalty Pharma plc⁸
• Nov 5, 2025Granted 36,559 shares of Royalty Pharma plc⁹
• Aug 6, 2025Granted 21,901 shares of Royalty Pharma plc¹⁰
• Jun 3, 2025Other 3,823,996 shares of PROKIDNEY CORP.⁵
• Jun 3, 2025Converted 3,823,996 shares of PROKIDNEY CORP.⁵
• May 16, 2025Other 530,348 shares of Royalty Pharma plc¹¹
• May 8, 2025Granted 288,352 shares of Royalty Pharma plc¹²
• Jun 13, 2024Bought 22,617,909 shares at $2.42 of PROKIDNEY CORP.¹³
• Feb 5, 2024Other 748,952 shares of PROKIDNEY CORP.¹⁴
• Feb 5, 2024Converted 748,952 shares of PROKIDNEY CORP.¹⁴
• Nov 16, 2023Other 383,000 shares of Royalty Pharma plc¹⁵
• Oct 30, 2023Other 5,289,055 shares of PROKIDNEY CORP.¹⁶
• Oct 30, 2023Converted 5,289,055 shares of PROKIDNEY CORP.¹⁶
• Jun 28, 2023Bought 130,000 shares at $29.51 of Royalty Pharma plc¹⁷
• Jun 13, 2023Bought 45,000 shares at $32.78 of Royalty Pharma plc¹⁸
• Jun 12, 2023Bought 45,000 shares at $33.00 of Royalty Pharma plc¹⁸
• May 24, 2023Bought 150,000 shares at $32.25 of Royalty Pharma plc¹⁹
• May 17, 2023Bought 69,612 shares at $32.94 of Royalty Pharma plc²⁰
• May 16, 2023Bought 160,388 shares at $33.57 of Royalty Pharma plc²⁰
• Dec 30, 2022Gift 292,190 shares of Royalty Pharma plc¹⁵
• Aug 12, 2022U 31,933,334 shares of Epizyme, Inc.⁶
• Apr 14, 2022Other 350,000 shares of Royalty Pharma plc²¹
• Apr 14, 2022Other 462,031 shares of Royalty Pharma plc²¹